Isicom

Levodopa/Carbidopa, the active ingredient in Isicom, is a Levodopa/Carbidopa combination presented as an oral tablet for oral use. It is used to treat Parkinson's disease and Parkinsonian syndromes by increasing central dopamine levels while reducing peripheral side effects. The formulation pairs levodopa, a dopamine precursor, with carbidopa, an inhibitor of peripheral dopa decarboxylase, to enhance brain availability of dopamine.

GNH USA supplies Isicom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isicom (levodopa/carbidopa) is used in the management of movement disorders related to dopamine deficiency.

- Parkinson's disease: improves motor symptoms such as tremor, rigidity and bradykinesia. - Parkinsonian syndrome: restores functional ability by augmenting central dopamine. - Levodopa‑responsive Parkinsonism: provides symptomatic relief in conditions that respond to dopamine replacement.

Levodopa/carbidopa therapy is associated with a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Orthostatic hypotension: dizziness upon standing. - Dyskinesia: involuntary movements, especially with long‑term use. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: life‑threatening hyperthermia and rigidity. - Severe psychiatric disturbances: hallucinations or psychosis. - Cardiac arrhythmias: uncommon but potentially serious. - Severe allergic reactions: rash, angioedema or anaphylaxis.

When prescribing or dispensing levodopa/carbidopa, clinicians should consider several safety measures.

- Monitor blood pressure: watch for orthostatic drops, especially after dose initiation. - Assess psychiatric status: be alert for hallucinations or mood changes. - Evaluate renal and hepatic function: adjust therapy if impairment is present. - Review concomitant medications: avoid drugs that may exacerbate dyskinesia. - Store below 25°C: keep in the original pack, protect from moisture.

Levodopa/carbidopa may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics with strong dopamine blockade: may negate therapeutic effect.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance orthostatic hypotension. - Iron or vitamin B6 supplements: can reduce levodopa absorption. - SSRIs and SNRIs: may increase risk of serotonin syndrome when combined with MAO‑B inhibitors.